Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Operating Grant - PA: Cancer Research (bridge funding)

University of Alberta

$79,345.00

Role of Platelets in Angiogenesis: Selective PKC Inhibition Uncouples Platelet Hemostasis from Angiogenesis Promotion

EF 2009-10

Résumé
Platelets are circulating blood particles responsible for stopping bleeding by forming blood clots (platelet aggregates). Recently, evidence has emerged showing overlap of mechanisms involved in clot formation and those responsible for new blood vessel growth (angiogenesis). Regulating this overlap is the platelet. During wound healing, platelets link together (aggregate) forming a clot to arrest bleeding. Simultaneously, platelets release growth factors, from internal storage compartments known as alpha-granules, which stimulate the formation of new blood vessels. The new blood vessels then supply injured tissues with nutrients and oxygen to help heal wounds. Under pathological conditions, such as cancer, growing tumors tap into the supply of growth factors found in platelets. Thus, new tumor supplying blood vessels nourish the tumor helping it grow. Current drugs inhibit platelet aggregation and the release of blood vessel promoting growth factors; however, since clot formation is inhibited bleeding may result as a side effect. The proposed research will attempt to show that it is possible to block blood vessel promoting growth factor release from platelets, but not clot formation. Thus, we propose that it is possible to decrease tumor blood vessels and growth, without the side effect of bleeding.
Programme
Operating Grant - PA: Cancer Research (bridge funding)
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
199407
Name
Jurasz Paul K
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Cardiovascular System - C: Vascular System
Projecttitle
Role of Platelets in Angiogenesis: Selective PKC Inhibition Uncouples Platelet Hemostasis from Angiogenesis Promotion
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$79,345
Cihrequipment2
$0
Programname2
Operating Grant - PA: Cancer Research (bridge funding)
Keyworddelim
Aggregometry; Alpha-Granules; Angiogenesis; Flow Cytometry; Platelets; Protein Kinase C
Abstract
Platelets are circulating blood particles responsible for stopping bleeding by forming blood clots (platelet aggregates). Recently, evidence has emerged showing overlap of mechanisms involved in clot formation and those responsible for new blood vessel growth (angiogenesis). Regulating this overlap is the platelet. During wound healing, platelets link together (aggregate) forming a clot to arrest bleeding. Simultaneously, platelets release growth factors, from internal storage compartments known as alpha-granules, which stimulate the formation of new blood vessels. The new blood vessels then supply injured tissues with nutrients and oxygen to help heal wounds. Under pathological conditions, such as cancer, growing tumors tap into the supply of growth factors found in platelets. Thus, new tumor supplying blood vessels nourish the tumor helping it grow. Current drugs inhibit platelet aggregation and the release of blood vessel promoting growth factors; however, since clot formation is inhibited bleeding may result as a side effect. The proposed research will attempt to show that it is possible to block blood vessel promoting growth factor release from platelets, but not clot formation. Thus, we propose that it is possible to decrease tumor blood vessels and growth, without the side effect of bleeding.
Competitiondate
200909
Approvedterm2
1 yr 0 mth
Pinamesdelim
Jurasz, Paul K
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $79,345~ $0~